Mark Granoff
Internal Medicine · Los Angeles, CANPI 1124058474
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Amgen at 26.8% of the total. Reporting peaked in 2019 at $1,242 and has fallen 93.0% since, to $87 in 2021.
Across 81 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$443
- AbbVie$273
- Regeneron Healthcare Solutions, Inc.$122
- E.r. Squibb & Sons, L.L.C.$120
- Amarin Pharma, Inc.$100
- Lilly USA, LLC$69
- plus $526 from 16 others
What the payments were for
- Food & beverage$1,652100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 21 | $443 |
| AbbVie | 14 | $273 |
| Regeneron Healthcare Solutions, Inc. | 7 | $122 |
| E.r. Squibb & Sons, L.L.C. | 6 | $120 |
| Amarin Pharma, Inc. | 5 | $100 |
| Lilly USA, LLC | 4 | $69 |
| Sanofi-aventis U.S. LLC | 3 | $68 |
| GSK | 2 | $63 |
| Merck | 3 | $48 |
| Johnson & Johnson | 2 | $43 |
| Mylan Specialty L.p. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Mallinckrodt Enterprises LLC | 1 | $31 |
| Medtronic | 1 | $31 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| Bristol Myers Squibb | 1 | $26 |
| Novo Nordisk | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Terumo BCT, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
| AstraZeneca | 1 | $13 |
How this compares
$1,652 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Los Angeles
- William HardyLos Angeles$704K
- Soha DolatabadiLos Angeles$458K
- Matthew HerrmannLos Angeles$384K
- Koppany VisnyeiLos Angeles$287K
- Jaime BetancourtLos Angeles$286K
- William KingLos Angeles$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.